Skip to content
10-Q

Quarterly Report

EMERGE HEALTH INTERNATIONAL INC

0001477932-19-000756

← back to feed
Filed
Mar 1, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Mar 1, 2019 17.77M sh
Stockholders Equity Q3 2017 · Mar 31, 2017 $999.59K
Stockholders Equity Q3 2017 · Jun 30, 2016 $1.03M
Current Liabilities Q3 2017 · Mar 31, 2017 $308.39K
Current Liabilities Q3 2017 · Jun 30, 2016 $280.98K
Total Liabilities Q3 2017 · Mar 31, 2017 $318.69K
Total Liabilities Q3 2017 · Jun 30, 2016 $280.98K
Current Assets Q3 2017 · Mar 31, 2017 $808.94K
Current Assets Q3 2017 · Jun 30, 2016 $784.47K
Total Assets Q3 2017 · Mar 31, 2017 $1.32M
Total Assets Q3 2017 · Jun 30, 2016 $1.31M
Net Income Q3 2017 · Mar 31, 2017 −$172.42K
Net Income Q3 2017 · Mar 31, 2016 −$22.61K
Net Income Q3 2017 · Mar 31, 2016 −$42.55K
Capex Q3 2017 · Mar 31, 2016 $33.22K
Cash And Equivalents Q3 2017 · Mar 31, 2016 $96.56K
Cash And Equivalents Q3 2017 · Jun 30, 2015 $100.43K
Eps Basic Q3 2017 · Mar 31, 2016 $0.00
Eps Basic Q3 2017 · Mar 31, 2016 $0.00
Rd Expense Q3 2017 · Mar 31, 2016 $0
Operating Income Q3 2017 · Mar 31, 2016 −$30.64K
Operating Income Q3 2017 · Mar 31, 2016 −$84.9K
Gross Profit restated Q3 2017 · Mar 31, 2016 $134.66K
Gross Profit Q3 2017 · Mar 31, 2016 $507.03K
Cost Of Revenue Q3 2017 · Mar 31, 2016 $246.94K
Cost Of Revenue Q3 2017 · Mar 31, 2016 $726.79K
Revenue Q3 2017 · Mar 31, 2016 $381.6K
Revenue Q3 2017 · Mar 31, 2016 $1.23M